Instituto Grifols, S.a.

This study tested a medicine called Flebogamma® 5% DIF in 191 people with post-polio syndrome, a condition that causes new muscle weakness years after polio. The goal was to see if it could improve walking distance and reduce pain. The trial was stopped early, so results are limi…